November 15, 2023 | Healthline

As the popularity of Ozempic and Wegovy soar for their weight loss benefits, some doctors are concerned about disparities regarding access to these drugs. Fewer Black and Hispanic people are prescribed these medications, yet they are at greater risk for developing type 2 diabetes. AACE President Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, explains ways to make anti-obesity medications more accessible for everyone, in an article featured on healthline.com.

https://www.healthline.com/health-news/ozempic-access-racial-disparities